Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

PROKPROKIDNEY CORP.

Nasdaq · CIK 0001850270
Filer category<br>Emerging growth company
Entity typeoperating
SIC2836 Biological Products, (No Diagnostic Substances)
FY end1231
XBRL facts261

Identity from submissions API

NamePROKIDNEY CORP.
CIK0001850270
TickersPROK
ExchangesNasdaq
Entity typeoperating
Category<br>Emerging growth company
SIC2836 Biological Products, (No Diagnostic Substances)
EIN981586514
LEI—
Fiscal year end1231
State of incorporationE9 Cayman Islands
Phone336-999-7028
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • Social Capital Suvretta Holdings Corp. III (2021-04-21T04:00:00.000Z → 2022-07-11T04:00:00.000Z)
Business address
2000 FRONTIS PLAZA BLVD.
SUITE 250
WINSTON-SALEM
NC
27103
NC
Mailing address
2000 FRONTIS PLAZA BLVD.
SUITE 250
WINSTON-SALEM
NC
27103
NC

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

406 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-12 8-K 8-K 2.02,9.01 0001193125-26-458470 001-40560 261547259 34 621561 1 1
2026-11-12 10-Q 10-Q 0001193125-26-458448 001-40560 261547197 34 11695330 1 1
2026-11-12 424B5 424B5 0001193125-26-457084 333-299700 261543567 33 204065
2026-11-10 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-003506 333-299700 261542394 33 1896
2026-11-09 8-K 8-K 2.02,7.01,8.01,9.01 0001193125-26-452616 001-40560 261533754 34 19726091 1 1
2026-11-03 4 4 0001193125-26-445773 5865
2026-10-30 4 4 0001193125-26-441628 10172
2026-10-29 8-K 8-K 1.01,9.01 0001193125-26-438071 001-40560 261502888 34 150577 1 1
2026-10-29 S-3 S-3 0001193125-26-437924 333-299700 261502541 33 1613424 1 1
2026-08-20 4 4 0001193125-26-359349 13714
2026-08-18 144 xsl144X01/primary_doc.xml 0001628280-26-057713 001-40560 261291504 33 5519
2026-08-18 144 xsl144X01/primary_doc.xml 0001628280-26-057710 001-40560 261291489 33 5437
2026-08-12 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000895421-26-000226 005-92651 261267214 34 12551
2026-08-10 8-K 8-K 2.02,9.01 0001193125-26-342397 001-40560 261258529 34 565598 1 1
2026-08-10 10-Q 10-Q 0001193125-26-342373 001-40560 261258492 34 11255310 1 1
2026-08-06 4 4 0001193125-26-336856 15971
2026-07-06 4 4 0001193125-26-296160 5570
2026-06-15 4 4 0001193125-26-271337 10032
2026-06-10 3 3 0001193125-26-265815 22997
2026-05-29 4 4 0001193125-26-248262 5615
2026-05-29 4 4 0001193125-26-248259 5707
2026-05-29 4 4 0001193125-26-248256 5676
2026-05-29 4 4 0001193125-26-248249 5633
2026-05-29 4 4 0001193125-26-248226 5684
2026-05-29 4 4 0001193125-26-248221 5751
2026-05-29 4 4 0001193125-26-248215 5699
2026-05-29 8-K 8-K 5.07 0001193125-26-248210 001-40560 261044158 34 181176 1 1
2026-05-15 8-K 8-K 2.02,7.01,8.01,9.01 0001193125-26-225848 001-40560 26984431 34 16589680 1 1
2026-05-15 10-Q 10-Q 0001193125-26-225841 001-40560 26984425 34 9821413 1 1
2026-04-30 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001140361-26-018258 005-92651 26925925 34 21965
2026-04-30 4 FORM 4 0001140361-26-018234 26556
2026-04-17 ARS ARS 0001140361-26-015371 001-40560 26871567 34 1511874
2026-04-17 DEFA14A DEFA14A 0001140361-26-015369 001-40560 26871558 34 3364407
2026-04-17 DEF 14A DEF 14A 0001140361-26-015362 001-40560 26871529 34 3786542 1 1
2026-03-18 S-8 S-8 0001193125-26-113942 333-294403 26768975 33 366140 1 1
2026-03-18 8-K 8-K 2.02,9.01 0001193125-26-113893 001-40560 26768788 34 616353 1 1
2026-03-18 10-K 10-K 0001193125-26-113881 001-40560 26768700 34 17513080 1 1
2026-03-03 4 4 0001193125-26-086730 5379
2026-03-03 4 4 0001193125-26-086728 5398
2026-03-03 4 4 0001193125-26-086725 5370
2026-03-03 4 4 0001193125-26-086724 5384
2026-02-12 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000895421-26-000066 005-92651 26625324 34 12081
2026-02-02 8-K 8-K 7.01,8.01,9.01 0001193125-26-033594 001-40560 26587797 34 16886249 1 1
2026-01-12 8-K 8-K 7.01,9.01 0001193125-26-009807 001-40560 26524702 34 16805069 1 1
2025-11-18 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-003304 333-266683 251496546 33 1909
2025-11-14 4 4 0001193125-25-282922 10378
2025-11-12 144 xsl144X01/primary_doc.xml 0001628280-25-051650 001-40560 251473697 33 5110
2025-11-12 144 xsl144X01/primary_doc.xml 0001628280-25-051633 001-40560 251473447 33 5087
2025-11-10 8-K 8-K 2.02,9.01 0001193125-25-274314 001-40560 251466516 34 568968 1 1
2025-11-10 10-Q 10-Q 0001193125-25-274303 001-40560 251466506 34 11108006 1 1
2025-11-05 DEL AM DEL AM 0001140361-25-040375 333-266683 251451344 33 7023
2025-10-21 POS AM POS AM 0001140361-25-038845 333-266683 251408066 33 904104
2025-10-17 8-K 8-K 1.01 0001193125-25-242565 001-40560 251401203 34 150256 1 1
2025-08-12 8-K 8-K 2.02,9.01 0000950170-25-107357 001-40560 251207020 34 612891 1 1
2025-08-12 10-Q 10-Q 0000950170-25-107352 001-40560 251206994 34 11417650 1 1
2025-08-07 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000895421-25-000479 005-92651 251192528 34 12510
2025-07-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002052113-25-002974 005-92651 251132148 34 10882
2025-07-16 8-K12B/A 8-K12B/A 1.01,3.03,5.02,5.03,8.01,9.01 0001140361-25-026049 001-40560 251127861 34 222520 1 1
2025-07-15 8-K 8-K 7.01,8.01,9.01 0001193125-25-159041 001-40560 251123092 34 2600926 1 1
2025-07-14 8-K 8-K 1.01,1.02,8.01,9.01 0001193125-25-158806 001-40560 251122407 34 419719 1 1
2025-07-14 424B5 424B5 0001140361-25-025800 333-275701 251122312 33 569251
2025-07-11 4 xslF345X05/form4.xml 0000899140-25-000834 3713
2025-07-09 4 4 0000950170-25-094797 4808
2025-07-08 144 xsl144X01/primary_doc.xml 0001950047-25-004905 001-40560 251111264 33 4924
2025-07-08 8-K 8-K 7.01,9.01 0000950170-25-094445 001-40560 251109514 34 9507677 1 1
2025-07-07 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-002177 333-286278 251109456 33 1909
2025-07-07 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-002174 333-275701 251109453 33 1909
2025-07-07 POS AM POS AM 0001140361-25-024903 333-275701 251106677 33 1033121
2025-07-03 S-8 POS S-8 POS 0001140361-25-024883 333-285975 251106416 33 100738
2025-07-03 S-8 POS S-8 POS 0001140361-25-024882 333-278176 251106415 33 100738
2025-07-03 S-8 POS S-8 POS 0001140361-25-024881 333-270920 251106414 33 100738
2025-07-03 S-8 POS S-8 POS 0001140361-25-024880 333-267414 251106413 33 100738
2025-07-03 POS AM POS AM 0001140361-25-024879 333-286278 251106412 33 124902
2025-07-03 8-K12B 8-K12B 1.01,3.03,5.02,5.03,8.01,9.01 0001140361-25-024839 001-40560 251105524 34 1341601
2025-07-01 8-K 8-K 7.01,9.01 0001140361-25-024348 001-40560 251095276 34 185364 1 1
2025-06-05 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001315863-25-000444 005-92651 251027342 34 10600
2025-06-05 4 4 0000950170-25-082342 14680
2025-06-02 4 4 0000950170-25-080277 5617
2025-06-02 4 4 0000950170-25-080272 5550
2025-06-02 4 4 0000950170-25-080269 5543
2025-06-02 4 4 0000950170-25-080267 5573
2025-06-02 4 4 0000950170-25-080265 5542
2025-06-02 4 4 0000950170-25-080261 5403
2025-06-02 4 4 0000950170-25-080260 5481
2025-05-30 8-K 8-K 5.07,7.01 0000950170-25-079685 001-40560 251010692 34 296935 1 1
2025-05-12 8-K 8-K 2.02,9.01 0000950170-25-069254 001-40560 25935132 34 543413 1 1
2025-05-12 10-Q 10-Q 0000950170-25-069251 001-40560 25935123 34 9525453 1 1
2025-05-06 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000895421-25-000348 005-92651 25917000 34 12208
2025-04-28 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-001268 333-286278 25882442 33 1895
2025-04-28 ARS ARS 0001140361-25-016074 001-40560 25881394 34 1878824
2025-04-28 424B3 424B3 0001140361-25-016063 333-286278 25881254 33 4117758
2025-04-24 CORRESP filename1.htm 0001140361-25-015455 7650
2025-04-24 4 FORM 4 0001140361-25-015444 22735
2025-04-21 4 FORM 4 0001140361-25-014756 22448
2025-04-18 4 FORM 4 0001140361-25-014571 22427
2025-04-16 4 FORM 4 0001140361-25-014211 24187
2025-04-14 4 FORM 4 0001140361-25-013770 28283
2025-04-04 UPLOAD filename1.pdf 0000000000-25-003629 333-286278 40314
2025-03-31 S-4 S-4 0001140361-25-011383 333-286278 25794769 33 5008667 1 1
2025-03-20 S-8 S-8 0000950170-25-042760 333-285975 25757372 33 232966
2025-03-17 10-K 10-K 0000950170-25-040483 001-40560 25745680 34 19632522 1 1
2025-03-17 8-K 8-K 2.02,9.01 0000950170-25-040417 001-40560 25745282 34 612871 1 1
2025-03-04 4 4 0000950170-25-032255 5393
2025-03-04 4 4 0000950170-25-032251 5407
2025-03-04 4 4 0000950170-25-032249 5361
2025-03-04 4 4 0000950170-25-032247 5406
2025-02-06 4 4 0000950170-25-015495 14705
2025-02-06 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001011438-25-000080 005-92651 25597977 34 10607
2025-02-06 4 4 0000950170-25-015369 15727
2025-01-21 8-K 8-K 1.01 0000950170-25-007217 001-40560 25542519 34 156004 1 1
2024-11-22 8-K 8-K 1.01 0000950170-24-130207 001-40560 241489820 34 155072 1 1
2024-11-12 10-Q 10-Q 0000950170-24-125312 001-40560 241447844 34 8106066 1 1
2024-11-12 8-K 8-K 2.02,9.01 0000950170-24-124585 001-40560 241443347 34 470417 1 1
2024-11-08 SC 13G kyg7s53r1049_110824.txt 0002012383-24-003655 005-92651 241439785 34 13846
2024-11-08 SC 13G/A MS AMENDMENT 0000895421-24-000594 005-92651 241438398 34 17787
2024-10-22 SC 13G/A SCHEDULE 13G/A, AMENDMENT #3 0000899140-24-001094 005-92651 241386227 34 79133
2024-10-22 3 xslF345X02/form3.xml 0000899140-24-001093 10568
2024-10-18 SC 13G kyg7s53r1049_101824.txt 0002012383-24-000636 005-92651 241380600 34 13834
2024-09-20 4 4 0000950170-24-108438 4824
2024-09-19 144 xsl144X01/primary_doc.xml 0001950047-24-007271 001-40560 241310709 33 5655
2024-09-16 4 4 0000950170-24-106912 5745
2024-09-04 4 4 0000950170-24-103630 5370
2024-09-03 8-K 8-K 7.01,8.01,9.01 0000950170-24-102554 001-40560 241271921 34 12427220 1 1
2024-08-09 10-Q 10-Q 0000950170-24-094732 001-40560 241192501 34 8151044 1 1
2024-08-09 8-K 8-K 2.02,9.01 0000950170-24-094341 001-40560 241190391 34 461377 1 1
2024-08-02 4 4 0000950170-24-089935 9831
2024-07-29 4 4 0000950170-24-087273 5341
2024-06-25 SC 13D/A SC 13D/A 0001140361-24-031299 005-92651 241069002 34 276812
2024-06-25 4 FORM 4 0001140361-24-031298 22114
2024-06-20 4 4 0000950170-24-075563 5345
2024-06-14 4 4 0000950170-24-073633 6728
2024-06-14 SC 13D/A sc_13da_tolerantia.htm 0001315863-24-000510 005-92651 241044595 34 52911
2024-06-13 8-K 8-K 1.01,8.01,9.01 0001193125-24-160339 001-40560 241040112 34 609255 1 1
2024-06-13 424B5 424B5 0001193125-24-160288 333-275701 241039996 33 506108
2024-06-10 424B5 424B5 0001193125-24-158443 333-275701 241033758 33 505648
2024-06-10 8-K 8-K 7.01,8.01,9.01 0001193125-24-157913 001-40560 241031501 34 6188353 1 1
2024-06-03 4 4 0000950170-24-068072 5546
2024-06-03 4 4 0000950170-24-068047 5554
2024-06-03 4 4 0000950170-24-068045 5622
2024-06-03 4 4 0000950170-24-068043 5547
2024-06-03 4 4 0000950170-24-068040 5577
2024-06-03 4 4 0000950170-24-068038 5407
2024-06-03 4 4 0000950170-24-068034 5485
2024-05-31 8-K 8-K 5.07 0000950170-24-067341 001-40560 241010006 34 175132 1 1
2024-05-29 8-K 8-K 7.01,9.01 0001140361-24-027808 001-40560 24993987 34 2003292 1 1
2024-05-22 4 4 0000950170-24-063281 5344
2024-05-20 144 xsl144X01/primary_doc.xml 0001950047-24-003920 001-40560 24964904 33 8568
2024-05-16 4 FORM 4 0001140361-24-026549 30407
2024-05-10 10-Q 10-Q 0000950170-24-057785 001-40560 24934707 34 7162513 1 1
2024-05-10 8-K 8-K 2.02,9.01 0000950170-24-057443 001-40560 24932855 34 426276 1 1
2024-04-26 ARS ARS 0001140361-24-022487 001-40560 24884300 34 10787180
2024-04-26 DEF 14A DEF 14A 0001140361-24-022484 001-40560 24884280 34 2251249
2024-04-23 4 4 0000950170-24-046887 7292
2024-04-18 144 xsl144X01/primary_doc.xml 0001950047-24-003129 001-40560 24854504 33 7183
2024-04-17 4 4 0000950170-24-045248 4832
2024-04-16 4 4 0000950170-24-044836 6772
2024-04-16 144 xsl144X01/primary_doc.xml 0001950047-24-003106 001-40560 24848084 33 6430
2024-04-12 144 xsl144X01/primary_doc.xml 0001950047-24-003051 001-40560 24841669 33 5677
2024-04-02 4 4 0000950170-24-040140 5417
2024-04-02 3 3 0000950170-24-040131 14382
2024-04-01 144 xsl144X01/primary_doc.xml 0001950047-24-002772 001-40560 24809616 33 4922
2024-03-25 8-K 8-K 5.02,7.01,9.01 0000950170-24-035914 001-40560 24779271 34 282738 1 1
2024-03-22 S-8 S-8 0000950170-24-035330 333-278176 24775178 33 229839
2024-03-22 8-K 8-K 2.02,9.01 0000950170-24-034961 001-40560 24772783 34 509561 1 1
2024-03-22 10-K 10-K 0000950170-24-034946 001-40560 24772752 34 13323058 1 1
2024-03-18 8-K/A 8-K/A 5.02,9.01 0000950170-24-032827 001-40560 24759092 34 246808 1 1
2024-03-18 8-K/A 8-K/A 5.02,9.01 0000950170-24-032821 001-40560 24759015 34 246274 1 1
2024-03-05 4 4 0000950170-24-025919 5389
2024-03-05 4 4 0000950170-24-025916 7614
2024-03-05 4 4 0000950170-24-025912 7647
2024-02-13 SC 13G/A d10978991_13g-a.htm 0000919574-24-001080 005-92651 24630222 34 149545
2024-02-12 8-K 8-K 5.02 0000950170-24-013823 001-40560 24619865 34 151666 1 1
2024-02-09 SC 13G/A MS AMENDMENT 0000895421-24-000166 005-92651 24614207 34 17780
2024-02-06 4 4 0000950170-24-011720 9829
2024-02-06 4 4 0000950170-24-011718 9927
2024-02-06 4 4 0000950170-24-011711 14713
2024-02-06 SC 13D/A form_sc13da-prokidney.htm 0001011438-24-000068 005-92651 24600156 34 63850
2024-01-26 8-K 8-K 7.01,9.01 0001193125-24-015722 001-40560 24563828 34 11699630 1 1
2024-01-19 8-K 8-K 1.01,9.01 0001193125-24-011267 001-40560 24545837 34 460496 1 1
2024-01-19 424B5 424B5 0001193125-24-011262 333-275701 24545795 33 418966
2023-12-05 8-K/A 8-K/A 5.02,9.01 0000950170-23-068152 001-40560 231466580 34 259913 1 1
2023-12-05 4 FORM 4 SUBMISSION 0001209191-23-057385 6122
2023-11-30 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2023-11-30 09:00:00 9999999995-23-003507 333-275701 231457412 33 1854
2023-11-30 8-K 8-K 5.02 0001193125-23-285651 001-40560 231453946 34 148953 1 1
2023-11-28 CORRESP filename1.htm 0000950103-23-016653 9723
2023-11-27 UPLOAD filename1.pdf 0000000000-23-012875 40418
2023-11-22 S-3 FORM S-3 0000950103-23-016560 333-275701 231430123 33 1133718
2023-11-21 4 OWNERSHIP DOCUMENT 0001104659-23-120081 10219
2023-11-20 SC 13D/A SCHEDULE 13D/A 0001104659-23-119964 005-92651 231423462 34 100341
2023-11-20 8-K FORM 8-K 7.01,9.01 0000950103-23-016461 001-40560 231420659 34 207490 1 1
2023-11-17 4 OWNERSHIP DOCUMENT 0001104659-23-119652 14214
2023-11-14 4 OWNERSHIP DOCUMENT 0001104659-23-118332 16393
2023-11-14 10-Q 10-Q 0000950170-23-063688 001-40560 231405945 34 9327569 1 1
2023-11-14 8-K 8-K 2.02,9.01 0000950170-23-063326 001-40560 231401380 34 583026 1 1
2023-11-13 8-K 8-K 5.02,7.01,8.01,9.01 0001193125-23-276225 001-40560 231400222 34 11310511 1 1
2023-11-08 4 OWNERSHIP DOCUMENT 0001104659-23-115904 15860
2023-11-06 SC 13D/A SC 13D/A 0001104659-23-114414 005-92651 231377884 34 56047
2023-11-03 4 OWNERSHIP DOCUMENT 0001104659-23-114413 15863
2023-11-02 SC 13D sc13d_tolerantia.htm 0001011438-23-000577 005-92651 231369368 34 49530
2023-11-01 4 FORM 4 SUBMISSION 0001209191-23-054044 15298
2023-10-31 4 OWNERSHIP DOCUMENT 0001104659-23-113076 15862
2023-10-27 SC 13D/A SC 13D/A 0001104659-23-111829 005-92651 231351746 34 56173
2023-10-26 4 OWNERSHIP DOCUMENT 0001104659-23-111828 15861
2023-10-23 4 OWNERSHIP DOCUMENT 0001104659-23-110875 15862
2023-10-19 SC 13D/A SC 13D/A 0001104659-23-109960 005-92651 231333243 34 56552
2023-10-18 4 OWNERSHIP DOCUMENT 0001104659-23-109952 15862
2023-10-13 4 OWNERSHIP DOCUMENT 0001104659-23-109193 18043
2023-10-10 4 OWNERSHIP DOCUMENT 0001104659-23-108414 18041
2023-09-21 SC 13D/A SC 13D/A 0001104659-23-102849 005-92651 231269665 34 52989
2023-09-21 4 OWNERSHIP DOCUMENT 0001104659-23-102847 14219
2023-09-11 8-K 8-K 7.01,9.01 0000950170-23-047359 001-40560 231246726 34 16195993 1 1
2023-08-29 4 4 0000950170-23-045159 10096
2023-08-23 424B3 424B3 0001193125-23-218224 333-266683 231194846 33 403858
2023-08-21 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001193125-23-215956,2023-08-21 9999999995-23-002451 333-266683 231190893 33 1867
2023-08-18 POS AM POS AM 0001193125-23-215956 333-266683 231185933 33 497544
2023-08-11 424B3 424B3 0000950170-23-041628 333-266683 231161777 33 2053972
2023-08-10 8-K 8-K 2.02,9.01 0000950170-23-041417 001-40560 231160127 34 660774 1 1
2023-08-10 10-Q 10-Q 0000950170-23-041374 001-40560 231159901 34 10021956 1 1
2023-08-03 4 FORM 4 SUBMISSION 0001209191-23-044316 5590
2023-07-25 424B3 424B3 0000950170-23-034405 333-266683 231108602 33 65326
2023-07-25 3 FORM 3 SUBMISSION 0001209191-23-043290 6389
2023-07-18 8-K 8-K 8.01,9.01 0000950170-23-033261 001-40560 231093031 34 313374 1 1
2023-07-13 4 FORM 4 SUBMISSION 0001209191-23-042197 8062
2023-07-06 424B3 424B3 0000950170-23-032013 333-266683 231073726 33 103249
2023-07-03 4 FORM 4 SUBMISSION 0001209191-23-040425 5709
2023-07-03 4 FORM 4 SUBMISSION 0001209191-23-040424 5702
2023-07-03 4 FORM 4 SUBMISSION 0001209191-23-040423 5654
2023-07-03 4 FORM 4 SUBMISSION 0001209191-23-040422 5640
2023-07-03 4 FORM 4 SUBMISSION 0001209191-23-040421 5777
2023-07-03 4 FORM 4 SUBMISSION 0001209191-23-040420 5732
2023-07-03 4 FORM 4 SUBMISSION 0001209191-23-040419 5562
2023-06-30 8-K 8-K 5.07 0000950170-23-031101 001-40560 231061737 34 213987 1 1
2023-06-23 424B3 424B3 0001193125-23-173812 333-266683 231037758 33 27636
2023-06-16 8-K 8-K 1.01,9.01 0001193125-23-168973 001-40560 231021001 34 176068 1 1
2023-05-26 ARS ARS 0001140361-23-026832 001-40560 23963108 34 1343669
2023-05-26 DEF 14A DEF 14A 0001140361-23-026831 001-40560 23963105 34 2003548
2023-05-26 424B3 424B3 0000950170-23-024338 333-266683 23963065 33 1530566
2023-05-11 8-K 8-K 2.02,9.01 0000950170-23-021256 001-40560 23911201 34 589719 1 1
2023-05-11 10-Q 10-Q 0000950170-23-021232 001-40560 23911087 34 8296587 1 1
2023-04-27 10-K/A 10-K/A 0000950170-23-015265 001-40560 23856866 34 1459017 1 1
2023-04-21 424B3 424B3 0001193125-23-110553 333-266683 23836595 33 2701623
2023-04-20 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001193125-23-103800,2023-04-20 9999999995-23-000990 333-266683 23834389 33 1866
2023-04-17 POS AM POS AM 0001193125-23-103800 333-266683 23824615 33 9011183 1 1
2023-04-04 4 xslF345X04/form4.xml 0000899140-23-000514 11291
2023-03-29 S-8 S-8 0000950170-23-010413 333-270920 23771536 33 320000
2023-03-28 8-K 8-K 2.02,9.01 0000950170-23-010330 001-40560 23770180 34 657616 1 1
2023-03-28 10-K 10-K 0000950170-23-010324 001-40560 23770137 34 14756470 1 1
2023-03-07 424B3 424B3 0000950170-23-006465 333-266683 23712887 33 64727
2023-03-06 8-K 8-K 8.01,9.01 0000950170-23-006251 001-40560 23709196 34 15239422 1 1
2023-02-14 SC 13G/A SC 13G/A 0001193125-23-038161 005-92651 23625496 34 152943
2023-02-13 SC 13G/A SCHEDULE 13G/A, AMENDMENT #1 0000899140-23-000306 005-92651 23619143 34 87388
2023-02-10 SC 13G/A PROK_SC13GA_2023.htm 0001319244-23-000040 005-92651 23612806 34 180876
2023-02-10 SC 13G/A MS AMENDMENT 0000895421-23-000214 005-92651 23610424 34 17693
2023-02-09 SC 13G/A PROKIDNEY CORP. 0000902664-23-001324 005-92651 23601965 34 100372
2023-02-06 424B3 424B3 0000950170-23-001889 333-266683 23590886 33 55089
2023-02-06 8-K 8-K 8.01 0000950170-23-001888 001-40560 23590842 34 168014 1 1
2023-01-20 424B3 424B3 0000950170-23-000945 333-266683 23538857 33 75478
2023-01-19 8-K 8-K 5.02,9.01 0000950170-23-000923 001-40560 23537637 34 624642 1 1
2023-01-18 4 FORM 4 SUBMISSION 0001209191-23-003720 5480
2023-01-18 4 FORM 4 SUBMISSION 0001209191-23-003719 5537
2023-01-18 4 FORM 4 SUBMISSION 0001209191-23-003717 5545
2023-01-18 4 FORM 4 SUBMISSION 0001209191-23-003714 5525
2023-01-18 4 FORM 4 SUBMISSION 0001209191-23-003713 5486
2023-01-18 4 FORM 4 SUBMISSION 0001209191-23-003711 5530
2023-01-18 4 FORM 4 SUBMISSION 0001209191-23-003705 5533
2023-01-11 424B3 424B3 0000950170-23-000669 333-266683 23523871 33 95401
2023-01-10 8-K 8-K 8.01,9.01 0000950170-23-000618 001-40560 23521364 34 317435 1 1
2023-01-10 8-K 8-K 7.01,9.01 0000950170-23-000572 001-40560 23519769 34 15628171 1 1
2023-01-06 4 FORM 4 SUBMISSION 0001209191-23-002376 5576
2023-01-06 3 FORM 3 SUBMISSION 0001209191-23-002375 10022
2022-12-08 424B3 424B3 0000950170-22-026241 333-266683 221452824 33 92923
2022-12-06 8-K 8-K 5.02,9.01 0000950170-22-026096 001-40560 221448091 34 206177 1 1
2022-11-29 424B3 424B3 0000950170-22-025799 333-266683 221433020 33 1925556
2022-11-14 8-K 8-K 2.02,9.01 0000950170-22-024799 001-40560 221381816 34 711249 1 1
2022-11-14 10-Q 10-Q 0000950170-22-024794 001-40560 221381692 34 8187982 1 1
2022-10-24 4 FORM 4 SUBMISSION 0001209191-22-054435 5539
2022-10-24 4 FORM 4 SUBMISSION 0001209191-22-054432 5547
2022-10-24 4 FORM 4 SUBMISSION 0001209191-22-054431 5527
2022-10-24 4 FORM 4 SUBMISSION 0001209191-22-054429 5488
2022-10-24 4 FORM 4 SUBMISSION 0001209191-22-054427 5533
2022-10-24 4 FORM 4 SUBMISSION 0001209191-22-054426 6145
2022-09-22 4 FORM 4 SUBMISSION 0001209191-22-051021 5511
2022-09-14 S-8 S-8 0000950170-22-018489 333-267414 221243223 33 503023
2022-09-12 SC 13G MS INITIAL 0000895421-22-000568 005-92651 221239270 34 20739
2022-09-09 424B3 424B3 0001193125-22-242057 333-266683 221236797 33 3395870
2022-09-08 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2022-09-08 16:00:00 9999999995-22-002632 333-266683 221234941 33 1854
2022-09-08 4 FORM 4 0001567619-22-017178 9028
2022-09-08 8-K 8-K 7.01,9.01 0000950170-22-018206 001-40560 221232491 34 3252562 1 1
2022-09-06 CORRESP filename1.htm 0001193125-22-238988 11281
2022-09-01 4 FORM 4 0001567619-22-016896 13174
2022-08-26 CORRESP filename1.htm 0001193125-22-231306 20105
2022-08-26 S-1/A S-1/A 0001193125-22-231275 333-266683 221205182 33 15173691 1 1
2022-08-15 UPLOAD filename1.pdf 0000000000-22-008689 49587
2022-08-12 8-K/A 8-K/A 2.01,9.01 0000950170-22-016997 001-40560 221157804 34 2402059 1 1
2022-08-12 10-Q 10-Q 0001193125-22-218857 001-40560 221157449 34 3392167 1 1
2022-08-12 8-K 8-K 2.02,9.01 0000950170-22-016952 001-40560 221157104 34 567322 1 1
2022-08-09 S-1 S-1 0001193125-22-215250 333-266683 221146034 33 15759256 1 1
2022-07-22 SC 13D SC 13D 0001193125-22-200105 005-92651 221100345 34 201141
2022-07-22 SC 13D SC 13D 0001193125-22-200092 005-92651 221100306 34 82672
2022-07-22 SC 13G SCHEDULE 13G 0000899140-22-000615 005-92651 221097982 34 94481
2022-07-21 3 FORM 3 0001567619-22-014307 8877
2022-07-21 SC 13G/A SC 13G/A 0001104659-22-081607 005-92651 221097486 34 68316
2022-07-20 3 FORM 3 SUBMISSION 0001209191-22-042691 6353
2022-07-20 4/A FORM 4/A SUBMISSION 0001209191-22-042683 15911
2022-07-20 SC 13D SC 13D 0001104659-22-081184 005-92651 221094568 34 854150
2022-07-15 8-K 8-K 1.01,2.01,3.02,3.03,4.01,5.01,5.02,5.03,5.06,8.01,9.01 0001193125-22-195148 001-40560 221087640 34 2479631 1 1
2022-07-13 4 xslF345X03/dp177014_4-weber.xml 0000950103-22-012378 9753
2022-07-13 4 FORM 4 0000950103-22-012377 9779
2022-07-13 4 FORM 4 0000950103-22-012376 9755
2022-07-13 4 FORM 4 0000950103-22-012375 9764
2022-07-13 4 FORM 4 0000950103-22-012374 9723
2022-07-13 4 FORM 4 0000950103-22-012373 9771
2022-07-13 4 FORM 4 0000950103-22-012372 16963
2022-07-13 4 FORM 4 0000950103-22-012371 9692
2022-07-13 4 xslF345X03/dp177005_4-girolamo.xml 0000950103-22-012370 9622
2022-07-13 4 FORM 4 0000950103-22-012369 9689
2022-07-13 4 FORM 4 0000950103-22-012368 10810
2022-07-13 4 FORM 4 0000950103-22-012367 15005
2022-07-13 4 FORM 4 0000950103-22-012366 9611
2022-07-13 3 xslF345X02/dp177025_3-jain.xml 0000950103-22-012365 10054
2022-07-13 3 xslF345X02/dp177017_3-fox.xml 0000950103-22-012364 9989
2022-07-13 3 xslF345X02/dp177016_3-lotvin.xml 0000950103-22-012363 11288
2022-07-13 3 xslF345X02/dp177013_3-weber.xml 0000950103-22-012362 9567
2022-07-13 3 xslF345X02/dp177022_3-maraganore.xml 0000950103-22-012361 10037
2022-07-13 3 xslF345X02/dp177019_3-mckenzie.xml 0000950103-22-012360 10124
2022-07-13 3 xslF345X02/dp177004_3-girolamo.xml 0000950103-22-012359 9235
2022-07-13 3 xslF345X02/dp177023_3-coulston.xml 0000950103-22-012358 10020
2022-07-13 3 xslF345X02/dp177024_3-doyle.xml 0000950103-22-012357 10004
2022-07-13 3 xslF345X02/dp177027_3-pereira.xml 0000950103-22-012356 10056
2022-07-13 3 xslF345X02/dp177021_3-control.xml 0000950103-22-012355 4301
2022-07-13 3 xslF345X02/dp177026_3-jimenez.xml 0000950103-22-012354 10071
2022-07-13 3 xslF345X02/dp177018_3-legorreta.xml 0000950103-22-012353 11619
2022-07-13 3 xslF345X02/dp176985_3-bertram.xml 0000950103-22-012352 9426
2022-07-13 4 FORM 4 SUBMISSION 0001209191-22-042046 13461
2022-07-13 4 FORM 4 SUBMISSION 0001209191-22-042045 14737
2022-07-12 8-K 8-K 3.01,5.02,5.07,7.01,8.01,9.01 0001193125-22-191769 001-40560 221078271 34 277387 1 1
2022-07-11 DEFA14A DEFA14A 0001193125-22-190656 001-40560 221075751 34 49991
2022-07-11 8-K 8-K 5.07,8.01,9.01 0001193125-22-190652 001-40560 221075749 34 185589 1 1
2022-07-06 DEFA14A DEFA14A 0001193125-22-188292 001-40560 221067471 34 32685
2022-07-06 8-K 8-K 8.01 0001193125-22-188289 001-40560 221067461 34 161168 1 1
2022-06-23 DEFA14A DEFA14A 0001193125-22-180197 001-40560 221035864 34 520890
2022-06-15 DEFA14A DEFA14A 0001193125-22-174800 001-40560 221018123 34 31122
2022-06-10 DEFM14A DEFM14A 0001193125-22-172036 001-40560 221009618 34 7751625
2022-06-10 8-K/A FORM 8-K/A 8.01,9.01 0001193125-22-171949 001-40560 221008994 34 267915 1 1
2022-06-08 DEFA14A DEFA14A 0001193125-22-170230 001-40560 221003894 34 324472
2022-06-07 DEFA14A DEFA14A 0001193125-22-169309 001-40560 221001551 34 29359
2022-05-26 DEFA14A DEFA14A 0001193125-22-161075 001-40560 22970753 34 68773
2022-05-20 DEFA14A DEFA14A 0001193125-22-156189 001-40560 22948104 34 32967
2022-05-17 UPLOAD filename1.pdf 0000000000-22-005389 39998
2022-05-16 10-Q FORM 10-Q 0001193125-22-151998 001-40560 22930840 34 3206346 1 1
2022-05-11 DEFA14A DEFA14A 0001193125-22-147608 001-40560 22914503 34 108386
2022-05-06 CORRESP filename1.htm 0001193125-22-143732 20622
2022-05-06 PRER14A PRER14A 0001193125-22-143727 001-40560 22901981 34 6926132
2022-05-03 DEFA14A DEFA14A 0001193125-22-138746 001-40560 22887508 34 37307
2022-04-28 DEFA14A DEFA14A 0001193125-22-127720 001-40560 22867258 34 26820
2022-04-28 DEFA14A DEFA14A 0001193125-22-125480 001-40560 22862320 34 16681442
2022-04-28 8-K 8-K 7.01,9.01 0001193125-22-125456 001-40560 22862293 34 16778593 1 1
2022-04-25 UPLOAD filename1.pdf 0000000000-22-004402 50798
2022-04-22 8-K FORM 8-K 1.01,2.03,9.01 0001193125-22-115149 001-40560 22845719 34 191201 1 1
2022-04-18 DEFA14A DEFA14A 0001193125-22-108053 001-40560 22832467 34 30537
2022-04-12 DEFA14A DEFA14A 0001193125-22-103003 001-40560 22822731 34 32656
2022-04-11 CORRESP filename1.htm 0001193125-22-101870 58875
2022-04-11 PRER14A PRER14A 0001193125-22-101864 001-40560 22820557 34 6808926
2022-03-28 DEFA14A DEFA14A 0001193125-22-086758 001-40560 22775979 34 31042
2022-03-24 10-K 10-K 0001193125-22-082906 001-40560 22764019 34 3865585 1 1
2022-03-17 UPLOAD filename1.pdf 0000000000-22-003012 75534
2022-03-01 DEFA14A DEFA14A 0001193125-22-061399 001-40560 22698775 34 38255
2022-02-14 PREM14A PREM14A 0001193125-22-042044 001-40560 22634008 34 7118112
2022-02-09 SC 13G SC 13G 0001193125-22-032750 005-92651 22607718 34 111721
2022-01-27 DEFA14A DEFA14A 0001193125-22-019863 001-40560 22563728 34 35529
2022-01-25 SC 13G/A DNAC_SC13GA1.htm 0001319244-22-000036 005-92651 22554188 34 167231
2022-01-21 DEFA14A DEFA14A 0001193125-22-014875 001-40560 22546422 34 2568843
2022-01-21 8-K/A 8-K/A 1.01,3.02,9.01 0001193125-22-014862 001-40560 22546359 34 3251032 1 1
2022-01-19 DEFA14A DEFA14A 0001193125-22-012554 001-40560 22539227 34 30891
2022-01-18 DEFA14A DEFA14A 0001193125-22-011357 001-40560 22535946 34 4936139
2022-01-18 DEFA14A DEFA14A 0001193125-22-010533 001-40560 22533627 34 26413515
2022-01-18 8-K FORM 8-K 1.01,3.02,7.01,9.01 0001193125-22-010520 001-40560 22533615 34 26611952 1 1
2021-12-29 SC 13G SC 13G 0001193125-21-369364 005-92651 211529693 34 161755
2021-11-16 8-K FORM 8-K 4.02 0001193125-21-331273 001-40560 211416554 34 153978 1 1
2021-11-15 10-Q FORM 10-Q 0001193125-21-330114 001-40560 211412330 34 3005033 1 1
2021-09-24 3 FORM 3 SUBMISSION 0001209191-21-057635 5886
2021-09-24 8-K 8-K 5.02,9.01 0001193125-21-282373 001-40560 211277568 34 400470 1 1
2021-08-16 4 FORM 4 SUBMISSION 0001209191-21-051681 12629
2021-08-16 10-Q FORM 10-Q 0001193125-21-247846 001-40560 211179098 34 2072361 1 1
2021-07-12 SC 13G SOCIAL CAPITAL SUVRETTA HOLDINGS CORP. III 0000902664-21-003473 005-92651 211085621 34 113354
2021-07-09 8-K FORM 8-K 8.01,9.01 0001193125-21-211210 001-40560 211081604 34 95149
2021-07-08 SC 13G DNAC_13G.htm 0001319244-21-000228 005-92651 211080469 34 143197
2021-07-07 4 FORM 4 SUBMISSION 0001209191-21-045953 14193
2021-07-02 8-K 8-K 1.01,3.02,5.02,5.03,8.01,9.01 0001193125-21-207646 001-40560 211070408 34 863017
2021-07-01 424B4 424B4 0001193125-21-206538 333-256725 211067037 33 1313878
2021-06-30 S-1MEF S-1MEF 0001193125-21-204042 333-257545 211060502 33 74754
2021-06-29 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2021-06-29 16:00:00 9999999995-21-002571 333-256725 211060282 33 1759
2021-06-29 3 FORM 3 SUBMISSION 0001209191-21-043849 20183
2021-06-29 3 FORM 3 SUBMISSION 0001209191-21-043832 7418
2021-06-29 3 FORM 3 SUBMISSION 0001209191-21-043822 5934
2021-06-29 3 FORM 3 SUBMISSION 0001209191-21-043794 5851
2021-06-29 CERT 8A_Cert_DNAC.pdf 0001354457-21-000735 001-40560 211056846 34 164022
2021-06-29 8-A12B 8-A12B 0001193125-21-202749 001-40560 211055996 34 14118
2021-06-25 CORRESP filename1.htm 0001193125-21-200673 7163
2021-06-25 CORRESP filename1.htm 0001193125-21-200670 8458

Latest XBRL company facts

One latest value per concept from companyfacts (261 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityPublicFloat Entity Public Float USD 58.87M 2025-06-30 2025 FY 10-K 2026-03-18 0001193125-26-113881
ffd NetFeeAmt NetFeeAmt USD 26,547.07 2026-10-28 S-3 2026-10-29 0001193125-26-437924
ffd TtlFeeAmt TtlFeeAmt USD 26,547.07 2026-10-28 S-3 2026-10-29 0001193125-26-437924
ffd TtlOfferingAmt TtlOfferingAmt USD 650.00M 2026-10-28 S-3 2026-10-29 0001193125-26-437924
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-10-28 S-3 2026-10-29 0001193125-26-437924
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-10-28 S-3 2026-10-29 0001193125-26-437924
us-gaap AccountsPayableAndAccruedLiabilitiesCurrent Accounts Payable and Accrued Liabilities, Current USD 0 2022-06-30 2022 Q2 10-Q 2022-08-12 0001193125-22-218857
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 2.52M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap AccruedIncomeTaxesNoncurrent Accrued Income Taxes, Noncurrent USD 1.12M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 26.41M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 458,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 20.82M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -37,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 447.04M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 10.56M 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-11 0000950170-23-021232
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 16.42M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap AmortizationOfIntangibleAssets Amortization of Intangible Assets USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-113881
us-gaap AssetImpairmentCharges Asset Impairment Charges USD 318,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap Assets Assets USD 210.28M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap AssetsCurrent Assets, Current USD 151.45M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap AssetsHeldForSaleNotPartOfDisposalGroupCurrentOther Assets Held-for-sale, Not Part of Disposal Group, Current, Other USD 0 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-113881
us-gaap AssetsHeldInTrustNoncurrent Assets Held-in-trust, Noncurrent USD 250.37M 2022-06-30 2022 Q2 10-Q 2022-08-12 0001193125-22-218857
us-gaap AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five USD 387,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One USD 88.17M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 88.56M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap BusinessAcquisitionCostOfAcquiredEntityTransactionCosts Business Acquisition, Transaction Costs USD 13.40M 2022-06-30 2022 Q2 10-Q 2022-08-12 0001193125-22-218857
us-gaap Cash Cash USD 490.25M 2022-12-31 2022 FY 10-K 2023-03-28 0000950170-23-010324
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 81.36M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD -388,599 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-16 0001193125-22-151998
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 81.36M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -27.18M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap CashEquivalentsAtCarryingValue Cash Equivalents, at Carrying Value USD 0 2021-12-31 2021 FY 10-K 2022-03-24 0001193125-22-082906
us-gaap CashFDICInsuredAmount Cash, FDIC Insured Amount USD 250,000 2022-06-30 2022 Q2 10-Q 2022-08-12 0001193125-22-218857
us-gaap CommonStockValue Common Stock, Value, Issued USD 64 2021-07-02 2021 Q3 10-Q 2021-11-15 0001193125-21-330114
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -84.14M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest USD -56.91M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest USD -141.06M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNet Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Change Due to Net Income Attributable to Parent and Effects of Changes, Net USD -255.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap ConstructionInProgressGross Construction in Progress, Gross USD 1.00M 2022-09-30 2022 Q3 10-Q 2022-11-14 0000950170-22-024794
us-gaap CurrentFederalStateAndLocalTaxExpenseBenefit Current Federal, State and Local, Tax Expense (Benefit) USD 414,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-113881
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD 378,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-113881
us-gaap CurrentForeignTaxExpenseBenefit Current Foreign Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-113881
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD 36,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-113881
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months USD 85,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap DebtSecuritiesAvailableForSaleUnrealizedLossPosition Debt Securities, Available-for-sale, Unrealized Loss Position USD 85,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions InvestmentPositions 57 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap DeferredFederalIncomeTaxExpenseBenefit Deferred Federal Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-113881
us-gaap DeferredFederalStateAndLocalTaxExpenseBenefit Deferred Federal, State and Local, Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-113881
us-gaap DeferredForeignIncomeTaxExpenseBenefit Deferred Foreign Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-113881
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 0 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-113881
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 379,666 2021-06-30 2021 Q2 10-Q 2021-08-16 0001193125-21-247846
us-gaap DeferredStateAndLocalIncomeTaxExpenseBenefit Deferred State and Local Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-113881
us-gaap DeferredTaxAssetsCapitalLossCarryforwards Deferred Tax Assets, Capital Loss Carryforwards USD 1.73M 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-113881
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 17.53M 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-113881
us-gaap DeferredTaxAssetsInvestments Deferred Tax Assets, Investments USD 191,000 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-113881
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-113881
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 0 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-113881
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 8.94M 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-113881
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsForeign Deferred Tax Assets, Operating Loss Carryforwards, Foreign USD 626,000 2024-12-31 2024 FY 10-K 2025-03-17 0000950170-25-040483
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 679,000 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-113881
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Bonuses USD 0 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-113881
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 57,000 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-113881
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 17.53M 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-113881
us-gaap DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets Deferred Tax Liabilities, Intangible Assets USD 0 2023-12-31 2023 FY 10-K 2024-03-22 0000950170-24-034946
us-gaap DeferredTaxLiabilitiesPrepaidExpenses Deferred Tax Liabilities, Prepaid Expenses USD 0 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-113881
us-gaap DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred Tax Liabilities, Property, Plant and Equipment USD 0 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-113881
us-gaap DefinedContributionPlanCostRecognized Defined Contribution Plan, Cost USD 1.10M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-113881
us-gaap Depreciation Depreciation USD 4.36M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 5.01M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap DueToRelatedPartiesCurrent Due to Related Parties, Current USD 80,687 2022-06-30 2022 Q2 10-Q 2022-08-12 0001193125-22-218857
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.23 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-28 0000950170-23-010324
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares 0 2021-02-25 2021-06-30 2021 Q2 10-Q 2021-08-16 0001193125-21-247846
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -0.23 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-28 0000950170-23-010324
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure -0.003 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-113881
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-113881
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.112 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-113881
us-gaap EffectiveIncomeTaxRateReconciliationCrossBorderOtherAmount EffectiveIncomeTaxRateReconciliationCrossBorderOtherAmount USD 9.06M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-113881
us-gaap EffectiveIncomeTaxRateReconciliationCrossBorderOtherPercent EffectiveIncomeTaxRateReconciliationCrossBorderOtherPercent pure -0.06 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-113881
us-gaap EffectiveIncomeTaxRateReconciliationDeductions Effective Income Tax Rate Reconciliation, Deduction, Percent pure 0.032 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-18 0001193125-26-113881
us-gaap EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense Effective Income Tax Rate Reconciliation, Noncontrolling Interest Income (Loss), Percent pure -0.115 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-113881
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure -0.012 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-113881
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure -0.002 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-113881
us-gaap EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent pure 0.063 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-113881
us-gaap EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent pure -0.015 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-18 0001193125-26-113881
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-113881
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsOther Effective Income Tax Rate Reconciliation, Tax Credit, Other, Percent pure -0.01 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-18 0001193125-26-113881
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure 0.025 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-113881
us-gaap EmployeeBenefitsAndShareBasedCompensation Employee Benefits and Share-based Compensation USD 16.27M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap EmployeeStockOwnershipPlanESOPSharesInESOP Employee Stock Ownership Plan (ESOP), Shares in ESOP shares 9.50M 2022-12-31 2022 FY 10-K 2023-03-28 0000950170-23-010324
us-gaap FinanceLeaseLiability Finance Lease, Liability USD 64,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap FinanceLeaseLiabilityCurrent Finance Lease, Liability, Current USD 18,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap FinanceLeaseLiabilityNoncurrent Finance Lease, Liability, Noncurrent USD 46,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap FinanceLeaseLiabilityPaymentsDue Finance Lease, Liability, Payment, Due USD 71,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap FinanceLeaseLiabilityPaymentsDueAfterYearFive Finance Lease, Liability, to be Paid, after Year Five USD 0 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-113881
us-gaap FinanceLeaseLiabilityPaymentsDueNextTwelveMonths Finance Lease, Liability, to be Paid, Year One USD 22,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap FinanceLeaseLiabilityPaymentsDueYearFive Finance Lease, Liability, to be Paid, Year Five USD 0 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-113881
us-gaap FinanceLeaseLiabilityPaymentsDueYearFour Finance Lease, Liability, to be Paid, Year Four USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap FinanceLeaseLiabilityPaymentsDueYearThree Finance Lease, Liability, to be Paid, Year Three USD 22,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap FinanceLeaseLiabilityPaymentsDueYearTwo Finance Lease, Liability, to be Paid, Year Two USD 22,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear Finance Lease, Liability, to be Paid, Remainder of Fiscal Year USD 5,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap FinanceLeaseLiabilityUndiscountedExcessAmount Finance Lease, Liability, Undiscounted Excess Amount USD 7,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap FinanceLeasePrincipalPayments Finance Lease, Principal Payments USD 12,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap FinanceLeaseRightOfUseAsset Finance Lease, Right-of-Use Asset, after Accumulated Amortization USD 60,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap FinanceLeaseWeightedAverageDiscountRatePercent Finance Lease, Weighted Average Discount Rate, Percent pure 0.056 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap FiniteLivedIntangibleAssetsAccumulatedAmortization Finite-Lived Intangible Assets, Accumulated Amortization USD 1.07M 2023-12-31 2023 FY 10-K 2024-03-22 0000950170-24-034946
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths Finite-Lived Intangible Asset, Expected Amortization, Year One USD 5,000 2023-09-30 2023 Q3 10-Q 2023-11-14 0000950170-23-063688
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year USD 47,000 2023-09-30 2023 Q3 10-Q 2023-11-14 0000950170-23-063688
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearThree Finite-Lived Intangible Asset, Expected Amortization, Year Three USD 5,000 2022-12-31 2022 FY 10-K 2023-03-28 0000950170-23-010324
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo Finite-Lived Intangible Asset, Expected Amortization, Year Two USD 208,000 2022-12-31 2022 FY 10-K 2023-03-28 0000950170-23-010324
us-gaap FiniteLivedIntangibleAssetsGross Finite-Lived Intangible Assets, Gross USD 1.07M 2023-12-31 2023 FY 10-K 2024-03-22 0000950170-24-034946
us-gaap FiniteLivedIntangibleAssetsNet Finite-Lived Intangible Assets, Net USD 0 2023-12-31 2023 FY 10-K 2024-03-22 0000950170-24-034946
us-gaap GainLossOnInvestments Gain (Loss) on Investments USD 811,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD -50,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap GainLossOnTerminationOfLease Gain (Loss) on Termination of Lease USD 29,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-113881
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 36.83M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap ImpairmentOfLongLivedAssetsToBeDisposedOf Impairment of Long-Lived Assets to be Disposed of USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -141.29M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap IncomeTaxesPaid Income Taxes Paid USD 73,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-18 0001193125-26-113881
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 2.44M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-113881
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD -436,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap IncomeTaxPaidFederalAfterRefundReceived IncomeTaxPaidFederalAfterRefundReceived USD 2.40M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-113881
us-gaap IncomeTaxPaidForeignAfterRefundReceived IncomeTaxPaidForeignAfterRefundReceived USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-113881
us-gaap IncomeTaxPaidStateAndLocalAfterRefundReceived IncomeTaxPaidStateAndLocalAfterRefundReceived USD 42,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-113881
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 16.75M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-113881
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -31.75M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-113881
us-gaap IncomeTaxReconciliationMinorityInterestIncomeExpense Effective Income Tax Rate Reconciliation, Noncontrolling Interest Income (Loss), Amount USD 17.35M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-113881
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 1.80M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-113881
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD 364,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-113881
us-gaap IncomeTaxReconciliationOtherReconcilingItems Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount USD -9.47M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-113881
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 28,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-113881
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD -3.72M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-113881
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD -1.65M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap IncreaseDecreaseInAccountsPayableTrade Increase (Decrease) in Accounts Payable, Trade USD 5,000 2021-02-25 2021-12-31 2021 FY 10-K 2022-03-24 0001193125-22-082906
us-gaap IncreaseDecreaseInAccruedIncomeTaxesPayable Increase (Decrease) in Income Taxes Payable USD 51,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap IncreaseDecreaseInAccruedInterestReceivableNet Increase (Decrease) in Accrued Interest Receivable, Net USD -501,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD 1.86M 2021-02-25 2021-12-31 2021 FY 10-K 2022-03-24 0001193125-22-082906
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD -575,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap IncreaseDecreaseInPrepaidExpense Increase (Decrease) in Prepaid Expense USD -226,939 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-08-12 0001193125-22-218857
us-gaap InterestExpense Interest Expense USD 17,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap InterestReceivable Interest Receivable USD 626,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 362,771 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-08-12 0001193125-22-218857
us-gaap InvestmentIncomeNonoperating Investment Income, Nonoperating USD 5.79M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 3.86M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 251,000 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-113881
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 1.29M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 420,000 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-113881
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 420,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 457,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 1.07M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 361,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 667,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap LessorOperatingLeasePaymentsToBeReceived Lessor, Operating Lease, Payments to be Received USD 918,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap LessorOperatingLeasePaymentsToBeReceivedFiveYears Lessor, Operating Lease, Payment to be Received, Year Five USD 0 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-113881
us-gaap LessorOperatingLeasePaymentsToBeReceivedFourYears Lessor, Operating Lease, Payment to be Received, Year Four USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths Lessor, Operating Lease, Payment to be Received, Year One USD 495,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear Lessor, Operating Lease, Payment to be Received, Remainder of Fiscal Year USD 121,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap LessorOperatingLeasePaymentsToBeReceivedThereafter Lessor, Operating Lease, Payment to be Received, after Year Five USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap LessorOperatingLeasePaymentsToBeReceivedThreeYears Lessor, Operating Lease, Payment to be Received, Year Three USD 13,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap LessorOperatingLeasePaymentsToBeReceivedTwoYears Lessor, Operating Lease, Payment to be Received, Year Two USD 289,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap Liabilities Liabilities USD 33.30M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 210.28M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap LiabilitiesCurrent Liabilities, Current USD 30.04M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap LiquidationBasisOfAccountingAccruedCostsToDisposeOfAssetsAndLiabilities Liquidation Basis of Accounting, Accrued Costs to Dispose of Assets and Liabilities USD 100,000 2021-07-02 2022 Q1 10-Q 2022-05-16 0001193125-22-151998
us-gaap MarketableSecurities Marketable Securities USD 60.51M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap MarketableSecuritiesGainLoss Marketable Securities, Gain (Loss) USD 2.31M 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-10 0000950170-24-057785
us-gaap MarketableSecuritiesUnrealizedGainLoss Marketable Securities, Unrealized Gain (Loss) USD -93,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap MinimumNetWorthRequiredForCompliance Minimum Net Worth Required for Compliance USD 5.00M 2021-07-02 2022 Q1 10-Q 2022-05-16 0001193125-22-151998
us-gaap MinorityInterestChangeInRedemptionValue Noncontrolling Interest, Change in Redemption Value USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-113881
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 804,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD 92.72M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -120.71M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -84.05M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap NetIncomeLossAttributableToRedeemableNoncontrollingInterest Net Income (Loss) Attributable to Redeemable Noncontrolling Interest USD -56.80M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance Noncontrolling Interest, Increase from Subsidiary Equity Issuance USD 14.79M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-17 0000950170-25-040483
us-gaap NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable Noncontrolling Interest in Net Income (Loss) Other Noncontrolling Interests, Redeemable USD -56.80M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap NotesPayableRelatedPartiesCurrentAndNoncurrent Notes Payable, Related Parties USD 25,643 2022-06-30 2022 Q2 10-Q 2022-08-12 0001193125-22-218857
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap OperatingExpenses Operating Expenses USD 147.61M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -147.06M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 1.02M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 3.19M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 1.09M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 2.10M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap OperatingLeasePayments Operating Lease, Payments USD 1.07M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 2.95M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.111 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 1.54M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap OtherAssetImpairmentCharges Other Asset Impairment Charges USD 318,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-113881
us-gaap OtherAssetsCurrent Other Assets, Current USD 1.25M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax USD -72,000 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-11 0000950170-23-021232
us-gaap OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax USD -206,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap OtherComprehensiveIncomeLossNetOfTax Other Comprehensive Income (Loss), Net of Tax USD -206,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent USD -18.91M 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-10 0000950170-23-041374
us-gaap OtherIncome Other Income USD 362,771 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-08-12 0001193125-22-218857
us-gaap OtherPrepaidExpenseCurrent Other Prepaid Expense, Current USD 3.98M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap PaymentsForRepurchaseOfCommonStock Payments for Repurchase of Common Stock USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-113881
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 0 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-08-12 0001193125-22-218857
us-gaap PaymentsToAcquireInvestments Payments to Acquire Investments USD 250.00M 2021-02-25 2021-12-31 2021 FY 10-K 2022-03-24 0001193125-22-082906
us-gaap PaymentsToAcquireMarketableSecurities Payments to Acquire Marketable Securities USD 76.79M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 8.85M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2022-06-30 2022 Q2 10-Q 2022-08-12 0001193125-22-218857
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 5.00M 2022-06-30 2022 Q2 10-Q 2022-08-12 0001193125-22-218857
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2022-06-30 2022 Q2 10-Q 2022-08-12 0001193125-22-218857
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2022-06-30 2022 Q2 10-Q 2022-08-12 0001193125-22-218857
us-gaap ProceedsFromContributedCapital Proceeds from Contributed Capital USD 6.05M 2022-01-01 2022-12-31 2024 FY 10-K 2025-03-17 0000950170-25-040483
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 245.60M 2021-02-25 2021-12-31 2021 FY 10-K 2022-03-24 0001193125-22-082906
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 7,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 6.40M 2021-02-25 2021-12-31 2021 FY 10-K 2022-03-24 0001193125-22-082906
us-gaap ProceedsFromIssuanceOrSaleOfEquity Proceeds from Issuance or Sale of Equity USD 136.62M 2024-06-01 2024-06-30 2025 FY 10-K 2026-03-18 0001193125-26-113881
us-gaap ProceedsFromNotesPayable Proceeds from Notes Payable USD 250,000 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-08-12 0001193125-22-218857
us-gaap ProceedsFromRelatedPartyDebt Proceeds from Related Party Debt USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-17 0000950170-25-040483
us-gaap ProceedsFromRepaymentsOfRelatedPartyDebt Proceeds from (Repayments of) Related Party Debt USD 0 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-08-12 0001193125-22-218857
us-gaap ProceedsFromSaleAndMaturityOfMarketableSecurities Proceeds from Sale and Maturity of Marketable Securities USD 178.36M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap ProceedsFromSaleOfIntangibleAssets Proceeds from Sale of Intangible Assets USD 18.21M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-113881
us-gaap ProceedsFromSaleOfMachineryAndEquipment Proceeds from Sale of Machinery and Equipment USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-22 0000950170-24-034946
us-gaap ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets Proceeds from Sales of Business, Affiliate and Productive Assets USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-17 0000950170-25-040483
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 809,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -140.85M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 55.81M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap RedeemableNoncontrollingInterestEquityOtherCarryingAmount Redeemable Noncontrolling Interest, Equity, Other, Carrying Amount USD 1.08B 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap RentalIncomeNonoperating Rental Income, Nonoperating USD 550,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap RepaymentsOfRelatedPartyDebt Repayments of Related Party Debt USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-17 0000950170-25-040483
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 110.78M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap RestrictedInvestmentsNoncurrent Restricted Investments, Noncurrent USD 250.00M 2021-09-30 2021 Q3 10-Q 2021-11-15 0001193125-21-330114
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -1.35B 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap RevenueFromContractWithCustomerIncludingAssessedTax Revenue from Contract with Customer, Including Assessed Tax USD 550,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 16.42M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested USD 1.68M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum pure 1.325 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-113881
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum pure 0.99 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-113881
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum pure 0.044 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-113881
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum pure 0.036 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-113881
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 3.64M 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-14 0000950170-22-024794
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 1.58M 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-113881
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 40.87M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost Share-based Payment Arrangement, Plan Modification, Incremental Cost USD 3.01M 2023-01-01 2023-12-31 2025 FY 10-K 2026-03-18 0001193125-26-113881
us-gaap SharePrice Share Price USD/shares 10 2021-06-30 2021 Q2 10-Q 2021-08-16 0001193125-21-247846
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD -906.85M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap StockIssued1 Stock Issued USD 0 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-08-12 0001193125-22-218857
us-gaap StockIssuedDuringPeriodSharesAcquisitions Stock Issued During Period, Shares, Acquisitions shares 17.50M 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-08-12 0001193125-22-218857
us-gaap StockIssuedDuringPeriodSharesRestrictedStockAwardGross Stock Issued During Period, Shares, Restricted Stock Award, Gross shares 50,000 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-11 0000950170-23-021232
us-gaap StockIssuedDuringPeriodValueIssuedForServices Stock Issued During Period, Value, Issued for Services USD 25,000 2021-02-25 2021-03-31 2022 Q2 10-Q 2022-08-12 0001193125-22-218857
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 7,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 811,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap TaxCreditCarryforwardAmount Tax Credit Carryforward, Amount USD 174,000 2022-12-31 2022 FY 10-K 2023-03-28 0000950170-23-010324
us-gaap TaxesPayableCurrent Taxes Payable, Current USD 0 2026-03-31 2026 Q1 10-Q 2026-05-15 0001193125-26-225841
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 250.37M 2022-06-30 2022 Q2 10-Q 2022-08-12 0001193125-22-218857
us-gaap TemporaryEquitySharesOutstanding Temporary Equity, Shares Outstanding shares 25.00M 2022-06-30 2022 Q2 10-Q 2022-08-12 0001193125-22-218857
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 1.07M 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-113881
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-113881
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense USD 0 2021-02-25 2021-12-31 2021 FY 10-K 2022-03-24 0001193125-22-082906
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 215,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-113881
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions USD 112,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-113881
us-gaap UnrecognizedTaxBenefitsPeriodIncreaseDecrease Unrecognized Tax Benefits, Period Increase (Decrease) USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458448
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 17.53M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-113881
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 61.54M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-28 0000950170-23-010324
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 5.50M 2021-02-25 2021-06-30 2021 Q2 10-Q 2021-08-16 0001193125-21-247846
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 61.54M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-28 0000950170-23-010324

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →